Table 1 Clinical information of patients with HNSCC included in this study
Characteristic |  | TCGA(n = 498) | GSE41613(n = 97) | GSE42743(n = 74) |
|---|---|---|---|---|
Status | Survival | 281(56.4%) | 46(47.5%) | 51(68.9%) |
Dead | 217(43.5%) | 51(52.5%) | 23(31.1%) | |
Age |  < 60 | 220(44.2%) | 50(51.6%) | 37(50%) |
 >  = 60 | 278(55.8%) | 47(48.4%) | 37(50%) | |
Gender | Female | 133(26.7%) | 31(31.9%) | 16(21.6%) |
Male | 365(73.3%) | 66(68.1%) | 58(78.4%) | |
T | T1 | 33(6.6%) | Â | Â |
T2 | 141(28.3%) | Â | Â | |
T3 | 130(26.1%) | Â | Â | |
T4 | 179(36%) | Â | Â | |
TX | 11(2.2%) | Â | Â | |
NA | 4(0.8%) | Â | Â | |
M | M0 | 468(94%) | Â | Â |
M1 | 5(1%) | Â | Â | |
MX | 20(4%) | Â | Â | |
NA | 5(1%) | Â | Â | |
N | N0 | 237(47.5%) | Â | Â |
N1 | 80(16%) | Â | Â | |
N2 | 152(30.5%) | Â | Â | |
N3 | 7(1.4%) | Â | Â | |
NX | 18(3.6%) | Â | Â | |
NA | 4(1%) | Â | Â | |
Stage | Stage I | 19(3.8%) | 41(42.3%) | 3(4.1%) |
Stage II | 93(18.6%) | Â | 27(36.5%) | |
Stage III | 102(20.4%) | 56(57.7%) | 28(37.8%) | |
Stage IV | 270(57.2%) | Â | 16(21.6%) | |
NA | 14(2.8%) | Â | Â | |
Grade | G1 | 61(12.2%) | Â | Â |
G2 | 298(59.9%) | Â | Â | |
G3 | 119(23.9%) | Â | Â | |
G4 | 2(0.4%) | Â | Â | |
GX | 15(3%) | Â | Â | |
NA | 3(0.6%) | Â | Â |